p450 - publications

Predict more p450 - ligand interactions now!


1. Bratisl Lek Listy. 2012;113(3):152-5.

Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and
MDR1 polymorphisms.

Slanar O, Dupal P, Matouskova O, Vondrackova H, Pafko P, Perlik F.

Objectives: The aim of our study was to evaluate impact of CYP2D6 and MDR1
polymorphisms on the analgesic efficacy of tramadol in patients after a knee
arthroscopy. Background : Pharmacokinetics of tramadol and its metabolites is
stereoselective and displays high interindividual variability correlating with
polymorphic CYP2D6 in the population. Available data provide controversial
results regarding the analgesic efficacy of tramadol in subjects with different
CYP2D6 genotypes.Methods: Pain intensity was assessed using visual analogue scale
at 2 and 24 hours after the knee arthroscopy in 156 patients. Polymorphisms
CYP2D6*3,*4,*5,*6, and gene duplication and C3435T in MDR1 gene were analyzed by
PCR - RFLP. Results: Mean VAS2h value in the whole study group was 44.0 ± 16.5
mm. Mean pain difference, was lowest in the UM group and highest in the PM group.
The pain difference varied significantly among the CYP2D6 subgroups (F = 4.29; p
= 0.006) with significant differences between homEM vs hetEM, homEM vs PM, and UM
vs PM subgroups. There were no significant differences among MDR1 subgroups with
regards of pain difference. Mean tramadol consumption was 2.47 ± 1.17 mg/kg
during the 24 h period. There were no significant differences in the drug
consumption, reporting of adverse reactions, need for rescue analgesic medication
or verbal description of pain among the CYP2D6 or MDR1 genotype subgroups.
Conclusion: CYP2D6 plays a significant role in tramadol analgesic efficacy. The
non-opioid analgesia in PMs was associated with better subjective pain relief in
patients after a knee arthroscopy (Tab. 3, Ref. 18). Keywords: analgesia,
tramadol, acute pain, polymorphism, arthroscopy.

PMID: 22428763 [PubMed - in process]